World's Best Scientists 2026 revealed!
Maura L. Furey

Maura L. Furey

D-Index & Metrics

Psychology

D-Index
49
Citations
16554
World Ranking
5553
National Ranking
78

Overview

Maura L. Furey is affiliated with Janssen (Belgium) and conducts research primarily in the fields of Neuroscience, Medicine, and Biochemistry, Genetics and Molecular Biology. Their work spans multiple subfields, including Pharmacology, Cellular and Molecular Neuroscience, Molecular Biology, Biological Psychiatry, and Experimental and Cognitive Psychology.

The main topics explored by this researcher focus on the Treatment of Major Depression, Receptor Mechanisms and Signaling, Tryptophan and brain disorders, Neurotransmitter Receptor Influence on Behavior, Neuropeptides and Animal Physiology, Mental Health Research Topics, and Functional Brain Connectivity Studies.

Recent publications by Maura L. Furey include the following:

  • Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials, 2020, The International Journal of Neuropsychopharmacology
  • The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions, 2020, Advances in pharmacology
  • Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder, 2020, Journal of Affective Disorders

Frequent co-authors working alongside Maura L. Furey include:

  • Wayne C. Drevets
  • Ziad S. Saad
  • Derrek P. Hibar
  • Maggie Fedgchin
  • Vanina Popova

Publication venues where this researcher has contributed work are:

  • The International Journal of Neuropsychopharmacology
  • Advances in pharmacology
  • Journal of Affective Disorders

Best Publications

  • Distributed and Overlapping Representations of Faces and Objects in Ventral Temporal Cortex

    James V. Haxby;M. Ida Gobbini;Maura L. Furey;Alumit Ishai

  • Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

    Wayne C. Drevets;Joseph L. Price;Maura L. Furey

  • Beyond sensory images: Object-based representation in the human ventral pathway

    Pietro Pietrini;Maura L. Furey;Emiliano Ricciardi;M. Ida Gobbini

  • Antidepressant Efficacy of the Antimuscarinic Drug Scopolamine: A Randomized, Placebo-Controlled Clinical Trial

    Maura L. Furey;Wayne C. Drevets

  • Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder.

    Teresa A. Victor;Maura L. Furey;Stephen J. Fromm;Arne Öhman

  • Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis

    Gene E. Alexander;Maura L. Furey;Cheryl L. Grady;Pietro Pietrini

  • Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease

    Cheryl L. Grady;Maura L. Furey;Pietro Pietrini;Barry Horwitz

  • Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease

    Vicente Ibáñez;Pietro Pietrini;Gene E. Alexander;Maura L. Furey

  • Cholinergic enhancement and increased selectivity of perceptual processing during working memory.

    Maura L. Furey;Pietro Pietrini;James V. Haxby

  • Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial.

    Wayne C. Drevets;Maura L. Furey

  • Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

    Elizabeth D. Ballard;Dawn F. Ionescu;Jennifer L. Vande Voort;Mark J. Niciu

  • Neural basis of abnormal response to negative feedback in unmedicated mood disorders

    Joana V. Taylor Tavares;Luke Clark;Maura L. Furey;Guy B. Williams

  • Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review

    Wayne C. Drevets;Carlos A. Zarate;Maura L. Furey

  • Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression

    Brian R. Cornwell;Giacomo Salvadore;Giacomo Salvadore;Maura Furey;Craig A. Marquardt

  • Abnormal brain glucose metabolism in the delusional misidentification syndromes: A positron emission tomography study in Alzheimer disease

    Marc J. Mentis;Edward A. Weinstein;Barry Horwitz;Andrew R. McIntosh

  • Scopolamine Produces Larger Antidepressant and Antianxiety Effects in Women Than in Men

    Maura L Furey;Ashish Khanna;Elana M Hoffman;Wayne C Drevets

  • Dissociation of face-selective cortical responses by attention.

    Maura L. Furey;Topi Tanskanen;Michael S. Beauchamp;Sari Avikainen

  • Network analysis of PET-mapped visual pathways in Alzheimer type dementia

    Barry Horwitz;Anthony R. McIntosh;James V. Haxby;Maura Furey

  • Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.

    Pietro Pietrini;Pietro Pietrini;Maura L. Furey;Neill R. Graff-Radford;Ulderico Freo

  • Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: a positron emission tomography regional cerebral blood flow study in healthy humans.

    Maura L Furey;Pietro Pietrini;Pietro Pietrini;Gene E Alexander;Mark B Schapiro

  • BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

    Christian R. Schubert;Patricio O’Donnell;Jie Quan;Jens R. Wendland

Frequent Co-Authors

Cheryl L. Grady
Cheryl L. Grady University of Toronto
Elizabeth D. Ballard
Elizabeth D. Ballard National Institutes of Health
Catherine J. Harmer
Catherine J. Harmer University of Oxford
Stephen J. Fromm
Stephen J. Fromm National Institutes of Health
Arne Öhman
Arne Öhman Karolinska Institute
Argyris Stringaris
Argyris Stringaris National Institutes of Health
Francis J. McMahon
Francis J. McMahon National Institutes of Health
H. Valerie Curran
H. Valerie Curran University College London
Barbara J. Sahakian
Barbara J. Sahakian University of Cambridge
Mitul A. Mehta
Mitul A. Mehta King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying psychology in the USA opens up diverse career pathways, many of which now offer accessible online degree options. One growing field is speech-language pathology (SLP), which combines psychology, communication, and healthcare. Professionals interested in this area should be aware that SLP certification and licensing differ by state.

For example, if you want to practice as an SLP in New Jersey, you must meet specific New Jersey slp certification requirements. Prospective SLPs in New Mexico should familiarize themselves with how to become a speech language pathologist in New Mexico. Similarly, there are unique slp requirements in New York and slp requirements in North Carolina.

Before choosing a program, research your intended career’s state-specific regulations. Many universities now offer online psychology and SLP programs, allowing greater flexibility. Combining your psychology studies with related degrees can broaden your employment options, from clinical settings to schools and research institutions.

Best Scientists Citing Maura L. Furey

Trending Scientists

Recently Published Articles